Daniel Morganstern

Tyrosine Kinases Expressed in Vivo by Human Prostate Cancer Bone Marrow Metastases and Loss of the Type 1 Insulin-Like Growth Factor Receptor

Andreas Chott, Zijie Sun, Daniel Morganstern et al. · American Journal Of Pathology · 1999 · 161 citations · Full text

Type 1, Urology, Receptor Tyrosine Kinase +6

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases

José Pablo Leone, Kyrre E. Emblem, Michelle Weitz et al. · Breast Cancer Research · 2020 · 50 citations · Full text

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

Stuart M. Lichtman, Constance Cirrincione, Arti Hurria et al. · Journal of Clinical Oncology · 2016 · 48 citations · Full text

Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).

Nancy U. Lin, Rebecca Gelman, W. Jerry Younger et al. · Journal of Clinical Oncology · 2013 · 42 citations

Neuro-oncology, Breast Oncology, Phase Ii Trial +15

Early Integration of Palliative and Supportive Care in the Cancer Continuum: Challenges and Opportunities

Mellar P. Davis, Éduardo Bruera, Daniel Morganstern · American Society of Clinical Oncology Educational Book · 2013 · 32 citations · Full text